IVM辅助生育技术发展的新方向 人类卵母细胞体外成熟培养系统为OHSS患者带来福音

来源 :首都食品与医药 | 被引量 : 0次 | 上传用户:xiaozhi_1100
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
在体外受精—胚胎移植(IVF)治疗周期中,为了提高成功率,临床上普遍采用大剂量的促性腺素,通过控制性超排卵在一个周期获得多枚成熟卵母细胞。但是随着促性腺素的广泛应用,其副作用也逐渐显现:最为突出的是卵巢过度刺激综合征(OHSS),不仅损害胚胎的植入和发育,重度的OHSS甚至危及母亲生命。其发生率为1%~4%。为解决 In the IVF cycle, in order to increase the success rate, it is commonly accepted that large doses of gonadotropins are clinically used to obtain multiple mature oocytes at one cycle through controlled superovulation. However, with the wide application of gonadotropin, its side effects gradually appear: the most prominent is ovarian hyperstimulation syndrome (OHSS), which not only impairs embryo implantation and development, but also seriously endangers mother’s life. The incidence rate of 1% to 4%. To solve
其他文献